Identification of differentially expressed microRNAs in human male breast cancer

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Lehmann, Ulrich ^a   Streichert, Thomas ^b   Otto, Benjamin ^b   Albat, Cord ^a   Hasemeier, Britta ^a   Christgen, Henriette ^a   Schipper, Elisa ^a   Hille, Ursula ^a   Kreipe, Hans H ^a   Länger, Florian ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 145; MICRORNA 183; MICRORNA 197; MICRORNA 21; MICRORNA 493 5P; MICRORNA 497; MICRORNA 519D; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; FLUORESCENCE ANALYSIS; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GENE TARGETING; GYNECOMASTIA; HUMAN; HUMAN TISSUE; MALE; MALE BREAST; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; TUMOR BIOPSY; UPREGULATION; VALIDATION PROCESS; BIOPSY; BREAST TUMOR; CLUSTER ANALYSIS; FLUORESCENCE MICROSCOPY; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BREAST NEOPLASMS, MALE; CLUSTER ANALYSIS; EPIGENESIS, GENETIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MICROSCOPY, FLUORESCENCE; MIDDLE AGED;

EID: 77952929240     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-109     Document Type: Article

References (31)

1. Fentiman IS, Fourquet A, Hortobagyi GN. Male breast cancer. Lancet 2006, 367(9510):595-604. 10.1016/S0140-6736(06)68226-3, 16488803.
2. Anderson WF, Althuis MD, Brinton LA, Devesa SS. Is male breast cancer similar or different than female breast cancer?. Breast Cancer Res Treat 2004, 83(1):77-86. 10.1023/B:BREA.0000010701.08825.2d, 14997057.
3. Garzon R, Calin GA, Croce CM. MicroRNAs in Cancer. Annu Rev Med 2009, 60:167-179. 10.1146/annurev.med.59.053006.104707, 19630570.
4. Khoshnaw SM, Green AR, Powe DG, Ellis IO. MicroRNA involvement in the pathogenesis and management of breast cancer. J Clin Pathol 2009, 62(5):422-428. 10.1136/jcp.2008.060681, 19398594.
5. Fassan M, Baffa R, Palazzo JP, Lloyd J, Crosariol M, Liu CG, Volinia S, Alder H, Rugge M, Croce CM, et al. MicroRNA expression profiling of male breast cancer. Breast Cancer Res 2009, 11(4):R58. 10.1186/bcr2348, 2750120, 19664288.
6. Hasemeier B, Christgen M, Kreipe H, Lehmann U. Reliable microRNA profiling in routinely processed formalin-fixed paraffin-embedded breast cancer specimens using fluorescence labelled bead technology. BMC Biotechnol 2008, 8:90. 10.1186/1472-6750-8-90, 2605753, 19038028.
7. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005, 65(16):7065-7070. 10.1158/0008-5472.CAN-05-1783, 16103053.
8. Yan LX, Huang XF, Shao Q, Huang MY, Deng L, Wu QL, Zeng YX, Shao JY. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. Rna 2008, 14(11):2348-2360. 10.1261/rna.1034808, 2578865, 18812439.
9. Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, Lund AH. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 2008, 283(2):1026-1033. 10.1074/jbc.M707224200, 17991735.
10. Xiao F, Zuo Z, Cai G, Kang S, Gao X, Li T. miRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Res 2009, (37 Database):D105-110. 10.1093/nar/gkn851, 2686554, 18996891.
11. Talotta F, Cimmino A, Matarazzo MR, Casalino L, De Vita G, D'Esposito M, Di Lauro R, Verde P. An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation. Oncogene 2009, 28(1):73-84. 10.1038/onc.2008.370, 18850008.
12. Weber F, Teresi RE, Broelsch CE, Frilling A, Eng C. A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma. J Clin Endocrinol Metab 2006, 91(9):3584-3591. 10.1210/jc.2006-0693, 16822819.
13. Dixon-McIver A, East P, Mein CA, Cazier JB, Molloy G, Chaplin T, Andrew Lister T, Young BD, Debernardi S. Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia. PLoS One 2008, 3(5):e2141. 10.1371/journal.pone.0002141, 2373886, 18478077.
14. Godlewski J, Nowicki MO, Bronisz A, Williams S, Otsuki A, Nuovo G, Raychaudhury A, Newton HB, Chiocca EA, Lawler S. Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res 2008, 68(22):9125-9130. 10.1158/0008-5472.CAN-08-2629, 19010882.
15. Du L, Schageman JJ, Subauste MC, Saber B, Hammond SM, Prudkin L, Wistuba II, Ji L, Roth JA, Minna JD, et al. miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1. Mol Cancer Res 2009, 7(8):1234-1243. 10.1158/1541-7786.MCR-08-0507, 19671678.
16. Schafer A, Jung M, Mollenkopf HJ, Wagner I, Stephan C, Jentzmik F, Miller K, Lein M, Kristiansen G, Jung K. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int J Cancer 2010, 126(5):1166-1176.
17. Motoyama K, Inoue H, Takatsuno Y, Tanaka F, Mimori K, Uetake H, Sugihara K, Mori M. Over- and under-expressed microRNAs in human colorectal cancer. Int J Oncol 2009, 34(4):1069-1075.
18. Selcuklu SD, Donoghue MT, Spillane C. miR-21 as a key regulator of oncogenic processes. Biochem Soc Trans 2009, 37(Pt 4):918-925. 10.1042/BST0370918, 19614619.
19. Cho WC, Chow AS, Au JS. Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation. Eur J Cancer 2009, 45(12):2197-2206. 10.1016/j.ejca.2009.04.039, 19493678.
20. Flavin RJ, Smyth PC, Laios A, O'Toole SA, Barrett C, Finn SP, Russell S, Ring M, Denning KM, Li J, et al. Potentially important microRNA cluster on chromosome 17p13.1 in primary peritoneal carcinoma. Mod Pathol 2009, 22(2):197-205. 10.1038/modpathol.2008.135, 18677302.
21. Sachdeva M, Zhu S, Wu F, Wu H, Walia V, Kumar S, Elble R, Watabe K, Mo YY. p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci USA 2009, 106(9):3207-3212. 10.1073/pnas.0808042106, 2651330, 19202062.
22. Chow TF, Crow M, Earle T, El-Said H, Diamandis EP, Yousef GM. Kallikreins as microRNA targets: an in silico and experimental-based analysis. Biol Chem 2008, 389(6):731-738. 10.1515/BC.2008.071, 18627289.
23. Elcheva I, Goswami S, Noubissi FK, Spiegelman VS. CRD-BP protects the coding region of betaTrCP1 mRNA from miR-183-mediated degradation. Mol Cell 2009, 35(2):240-246. 10.1016/j.molcel.2009.06.007, 19647520.
24. Fisher SE, Scharff C. FOXP2 as a molecular window into speech and language. Trends Genet 2009, 25(4):166-177. 10.1016/j.tig.2009.03.002, 19304338.
25. Braunstein GD. Clinical practice. Gynecomastia. N Engl J Med 2007, 357(12):1229-1237. 10.1056/NEJMcp070677, 17881754.
26. Blenkiron C, Goldstein LD, Thorne NP, Spiteri I, Chin SF, Dunning MJ, Barbosa-Morais NL, Teschendorff AE, Green AR, Ellis IO, et al. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol 2007, 8(10):R214. 10.1186/gb-2007-8-10-r214, 2246288, 17922911.
27. Ciocca V, Bombonati A, Gatalica Z, Di Pasquale M, Milos A, Ruiz-Orrico A, Dreher D, Folch N, Monzon F, Santeusanio G, et al. Cytokeratin profiles of male breast cancers. Histopathology 2006, 49(4):365-370. 10.1111/j.1365-2559.2006.02519.x, 16978199.
28. von Wasielewski R, Mengel M, Wiese B, Rudiger T, Muller-Hermelink HK, Kreipe H. Tissue array technology for testing interlaboratory and interobserver reproducibility of immunohistochemical estrogen receptor analysis in a large multicenter trial. Am J Clin Pathol 2002, 118(5):675-682. 10.1309/URLK-6AVK-331U-0V5P, 12428786.
29. Bock O, Kreipe H, Lehmann U. One-step extraction of RNA from archival biopsies. Anal Biochem 2001, 295(1):116-117. 10.1006/abio.2001.5188, 11476553.
30. Tessema M, Langer F, Dingemann J, Ganser A, Kreipe H, Lehmann U. Aberrant methylation and impaired expression of the p15(INK4b) cell cycle regulatory gene in chronic myelomonocytic leukemia (CMML). Leukemia 2003, 17(5):910-918. 10.1038/sj.leu.2402891, 12750705.
31. Christgen M, Bruchhardt H, Hadamitzky C, Rudolph C, Steinemann D, Gadzicki D, Hasemeier B, Romermann D, Focken T, Krech T, et al. Comprehensive genetic and functional characterization of IPH-926: a novel CDH1-null tumour cell line from human lobular breast cancer. J Pathol 2009, 217(5):620-632. 10.1002/path.2495, 19191266.